EBV-CTLs targeting CD19

epstein-barr virus-specific cytotoxic T-lymphocytes targeting CD19 · Memorial Sloan Kettering Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EBV-CTLs targeting CD19, covering 2025-06-11 to 2025-06-11. Get the full timeline:

Most recent: Clinical Trial Update: In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies [Phase 1]

See pricing